American Research & Management Company’s ExxonMobil XOM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $13.2M | Buy |
150,615
+174
| +0.1% | +$15.9K | 3.63% | 2 |
|
|
2022
Q2 | $12.9M | Buy |
150,441
+1,218
| +0.8% | +$110K | 3.31% | 3 |
|
|
2022
Q1 | $12.3M | Sell |
149,223
-1,367
| -0.9% | -$106K | 2.72% | 10 |
|
|
2021
Q4 | $9.21M | Sell |
150,590
-4,951
| -3% | -$309K | 1.99% | 21 |
|
|
2021
Q3 | $9.15M | Sell |
155,541
-1,585
| -1% | -$90.3K | 2.11% | 16 |
|
|
2021
Q2 | $9.91M | Sell |
157,126
-68
| -0% | -$4.06K | 2.26% | 15 |
|
|
2021
Q1 | $8.78M | Sell |
157,194
-4,126
| -3% | -$216K | 2.12% | 17 |
|
|
2020
Q4 | $6.65M | Sell |
161,320
-1,266
| -0.8% | -$47.5K | 1.73% | 20 |
|
|
2020
Q3 | $5.58M | Buy |
162,586
+14,910
| +10% | +$610K | 1.63% | 22 |
|
|
2020
Q2 | $6.6M | Buy |
147,676
+2,011
| +1% | +$90.2K | 2% | 18 |
|
|
2020
Q1 | $5.53M | Buy |
145,665
+2,703
| +2% | +$149K | 2.1% | 14 |
|
|
2019
Q4 | $9.98M | Sell |
142,962
-1,324
| -0.9% | -$91.6K | 2.95% | 8 |
|
|
2019
Q3 | $10.2M | Buy |
144,286
+5,141
| +4% | +$372K | 3.06% | 5 |
|
|
2019
Q2 | $10.7M | Buy |
139,145
+1,359
| +1% | +$105K | 3.19% | 5 |
|
|
2019
Q1 | $11.1M | Buy |
137,786
+4,277
| +3% | +$326K | 3.18% | 5 |
|
|
2018
Q4 | $9.1M | Sell |
133,509
-490
| -0.4% | -$38.4K | 3.07% | 6 |
|
|
2018
Q3 | $11.4M | Buy |
133,999
+553
| +0.4% | +$45.2K | 3.38% | 3 |
|
|
2018
Q2 | $11M | Buy |
133,446
+12,223
| +10% | +$974K | 3.84% | 3 |
|
|
2018
Q1 | $9.04M | Buy |
121,223
+2,703
| +2% | +$216K | 2.97% | 7 |
|
|
2017
Q4 | $9.91M | Buy |
118,520
+292
| +0.2% | +$24.1K | 3.06% | 5 |
|
|
2017
Q3 | $9.69M | Buy |
118,228
+1,220
| +1% | +$96.9K | 3.14% | 5 |
|
|
2017
Q2 | $9.45M | Sell |
117,008
-498
| -0.4% | -$40.7K | 3.1% | 5 |
|
|
2017
Q1 | $9.64M | Buy |
117,506
+664
| +0.6% | +$55.5K | 3.43% | 5 |
|
|
2016
Q4 | $10.5M | Sell |
116,842
-264
| -0.2% | -$23.1K | 3.61% | 3 |
|
|
2016
Q3 | $10.2M | Sell |
117,106
-93
| -0.1% | -$8.25K | 3.73% | 2 |
|
|
2016
Q2 | $11M | Buy |
117,199
+383
| +0.3% | +$33.9K | 4.22% | 2 |
|
|
2016
Q1 | $9.77M | Sell |
116,816
-250
| -0.2% | -$20K | 4.1% | 2 |
|
|
2015
Q4 | $9.13M | Sell |
117,066
-1,301
| -1% | -$104K | 3.9% | 2 |
|
|
2015
Q3 | $8.8M | Buy |
118,367
+7,278
| +7% | +$561K | 3.85% | 2 |
|
|
2015
Q2 | $9.24M | Sell |
111,089
-2,778
| -2% | -$239K | 3.75% | 3 |
|
|
2015
Q1 | $9.68M | Sell |
113,867
-2,032
| -2% | -$180K | 3.94% | 2 |
|
|
2014
Q4 | $10.7M | Sell |
115,899
-625
| -0.5% | -$58.3K | 3.95% | 3 |
|
|
2014
Q3 | $11M | Sell |
116,524
-1,538
| -1% | -$153K | 3.95% | 3 |
|
|
2014
Q2 | $11.9M | Sell |
118,062
-1,175
| -1% | -$119K | 4.13% | 3 |
|
|
2014
Q1 | $11.6M | Sell |
119,237
-2,053
| -2% | -$196K | 4.14% | 3 |
|
|
2013
Q4 | $12.3M | Sell |
121,290
-1,737
| -1% | -$161K | 4.38% | 3 |
|
|
2013
Q3 | $10.6M | Sell |
123,027
-1,688
| -1% | -$152K | 4.19% | 2 |
|
|
2013
Q2 | $11.3M | Buy |
+124,715
| New | +$11.2M | 4.53% | 2 |
|
Other funds holding XOM
American Research & Management Company's XOM Position: Q3 2022 in Review
American Research & Management Company increased its ExxonMobil (XOM) stake by 0.12% in Q3 2022, buying an estimated $15.9K and bringing the position to 150,615 shares worth $13.2M. The position accounts for 3.63% of the portfolio, ranked #2.
American Research & Management Company first reported a position in XOM in Q2 2013 and has held it in 38 quarters since. 3,218 funds tracked by Wall St. Rank hold XOM as of Q3 2022.
- American Research & Management Company held 150,615 shares of ExxonMobil worth $13.2M as of Q3 2022.
- American Research & Management Company bought 174 ExxonMobil shares in Q3 2022, an estimated $15.9K.
- ExxonMobil made up 3.63% of American Research & Management Company's portfolio in Q3 2022, its #2 holding.
- American Research & Management Company first reported a position in ExxonMobil in Q2 2013 and has held it in 38 quarters since.
- 3,218 funds tracked by Wall St. Rank held ExxonMobil as of Q3 2022.
Based on American Research & Management Company's 13F filing for Q3 2022, filed 7 Oct 2022.